Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Celecoxib Capsules Recalled for Presence of Foreign Tadalafil Tablets

Agency Publication Date: June 6, 2025
Share:
Sign in to monitor this recall

Summary

Alembic Pharmaceuticals Limited is recalling 2,946 bottles of Celecoxib (200 mg) capsules after a customer discovered a Tadalafil (5 mg) tablet inside a sealed 500-count bottle. Celecoxib (Celebrex) is a prescription nonsteroidal anti-inflammatory drug (NSAID) used for pain and arthritis, while Tadalafil (Cialis) is used for erectile dysfunction and pulmonary hypertension. Consumers should immediately verify if their bottle is part of the affected batch.

Risk

Taking an unintended medication like Tadalafil can cause a dangerous drop in blood pressure or lead to serious interactions with other prescription drugs, such as nitrates. There is a moderate risk of adverse health consequences if the wrong medication is consumed.

What You Should Do

  1. This recall affects 500-count bottles of Celecoxib Capsules (200 mg) labeled with NDC 62332-142-71, Batch number 2405014780, and an expiration date of Sep. 30, 2027.
  2. If you have health concerns or believe you have taken the wrong medication, contact your healthcare provider or pharmacist immediately.
  3. Return any unused product to the place of purchase for a refund, throw it away, or contact Alembic Pharmaceuticals Limited for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Celecoxib Capsules (200 mg, 500-count bottle)
Variants: 200 mg, 500-count bottle, Rx only
Lot Numbers:
2405014780 (Exp. Sep. 30, 2027)
NDC:
62332-142-71

Recall #: D-0459-2025. Recall initiated due to a customer complaint finding one Tadalafil 5mg tablet inside a sealed bottle.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 96840
Status: Active
Manufacturer: Alembic Pharmaceuticals Limited
Sold By: pharmacies; wholesale distributors
Manufactured In: India
Units Affected: 2,946 500-count bottles
Distributed To: Nationwide
Agency Last Updated: June 9, 2025

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.